EMD Serono Celebrates 10 Years of STEM Education Support at BIO International Convention
June 19, 2014 (Cambridge, MA) — EMD Serono’s President and Managing Director Paris Panayiotopoulos will celebrate the company’s longstanding commitment to Science, Technology, Engineering, and Math (STEM) education—including a 10-year, $500,000 investment in the MassBioEd Foundation—at the BIO International Convention in San Diego next week.
The Massachusetts Biotechnology Education Foundation (MassBioEd Foundation) is a nonprofit charitable organization that was founded in 2001 to bring biotechnology education to students and cultivate the next generation of life sciences professionals. EMD Serono became a MassBioEd Foundation partner in 2005, the year the foundation launched its signature BioTeach program.
The BioTeach program brings biotechnology curricula, teacher professional development, student career exploration experiences, and lab equipment funding to schools. In 2005, MassBioEd Foundation brought the BioTeach program to 34 schools in the Commonwealth. Ten years later, and with the generous support of many industry partners, the program reaches 201 schools and has been recognized as a premier Massachusetts State STEM Council @SCALE program.
EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, is one of the leading U.S. biopharmaceutical companies exclusively focused on specialty care. The company has a deep expertise in neurology, fertility and endocrinology, as well as a strong pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology.
“As a company with more than forty years of dedication to the life sciences community in Massachusetts, we share MassBioEd’s commitment of ensuring our students are educated and enthusiastic about science-based career opportunities.” said Paris Panayiotopoulos, President and Managing Director, EMD Serono. “We believe it’s essential to continue to nurture our future scientific leaders through organizations such as MassBioEd, ultimately supporting the longer-term growth of the Massachusetts innovation hub and contributing to future scientific discoveries on behalf of patients.”
“We would like to thank the team at EMD Serono for their commitment to advancing STEM education in Massachusetts,” said Lance Hartford, Executive Director of the MassBioEd Foundation. “With this level of industry support, along with government and nonprofit partnerships, we have created a statewide, systemic, STEM education program. Working together, we can and will continue to inspire and develop the scientific innovators of the future.”
Panayiotopoulos will speak at the Massachusetts Pavilion Reception which begins at 5 p.m. on June 24th in booth #2127 at the convention exhibit hall.
About MassBioEd Foundation
The Massachusetts Biotechnology Education Foundation (MassBioEd Foundation), founded in 2001, is a nonprofit charitable organization committed to supporting science and biotechnology education in Massachusetts through school programs, workforce development, and lifelong learning. Serving as a link between education, industry, and government, MassBioEd is working to ensure Massachusetts’ biotechnology sector, has an appropriately trained work force to meet the growing employment needs. MassBioEd’s BioTeach program provides professional development to more than 750 teachers in their biotechnology curricula and provides grants and lab equipment to 201 schools across the Commonwealth. MassBioEd’s Biotech Learning Center offers professional development courses for employees in the biotechnology sector to advance their professional skills.
About EMD Serono, Inc.
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a leading US biopharmaceutical company focused exclusively on specialty care. An established leader in the Massachusetts life sciences industry, EMD Serono recently invested in expanding its research and development presence in the state to support the advancement of its pipeline and opportunities for partnerships in the academia and biotech sectors. Today, the EMD presence in Massachusetts includes approximately 2,200 employees, and the combined organizations of EMD Serono and EMD Millipore, the life sciences division of Merck KGaA, make EMD the fifth largest life science company in Massachusetts. EMD Serono engages in strategic partnerships that leverage Massachusetts’ rich biotech innovation hub to advance research in our core therapeutic areas and is also a supporter of science, technology, engineering and medical (STEM) education in Massachusetts.
For more information, please visit www.emdserono.com.